Enlight (ENLT) vice chair sells shares after exercising 20,000 stock options
Rhea-AI Filing Summary
Enlight Renewable Energy vice chairman and director Yair Seroussi reported a combination of option exercises, tax withholdings and share sales in the company’s ordinary shares. He exercised stock options to acquire 20,000 ordinary shares at an exercise price of $23.22 per share, with 5,628 shares withheld to cover the exercise price and related obligations.
Seroussi sold 14,372 ordinary shares in open-market transactions at prices of $93.04 and $94.24 per share and now directly holds 14,233 ordinary shares. He also continues to hold performance-based RSUs covering 11,339 underlying shares and stock options covering 51,574 underlying shares, providing substantial remaining equity exposure.
Positive
- None.
Negative
- None.
Insights
Routine option exercises with partial share sales; sizeable equity stake remains.
Yair Seroussi, vice chairman of Enlight Renewable Energy, exercised options for 20,000 ordinary shares at an exercise price of $23.22 per share. A total of 5,628 shares were retained by the company to cover the option exercise price and related obligations, a standard non-market mechanism.
He then sold 14,372 ordinary shares in open-market transactions at $93.04 and $94.24 per share. Following these trades, he still directly holds 14,233 ordinary shares and retains performance-based RSUs over 11,339 shares plus options over 51,574 shares. This pattern reflects an exercise-and-sell sequence that provides liquidity while leaving a significant ongoing equity interest tied to future performance and share price.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Options (right to buy) | 5,000 | $0.00 | -- |
| Exercise | Stock Options (right to buy) | 15,000 | $0.00 | -- |
| Exercise | Ordinary shares, NIS 0.1 par value per share | 5,000 | $23.22 | $116K |
| Tax Withholding | Ordinary shares, NIS 0.1 par value per share | 1,407 | $94.24 | $133K |
| Sale | Ordinary shares, NIS 0.1 par value per share | 3,593 | $94.24 | $339K |
| Exercise | Ordinary shares, NIS 0.1 par value per share | 15,000 | $23.22 | $348K |
| Tax Withholding | Ordinary shares, NIS 0.1 par value per share | 4,221 | $93.04 | $393K |
| Sale | Ordinary shares, NIS 0.1 par value per share | 10,779 | $93.04 | $1.00M |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Performance-Based RSUs | -- | -- | -- |
Footnotes (1)
- Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026. Includes 7,117 restricted share units granted on April 17, 2024, with 3,558 vesting on and April 17, 2027 and 3,559 vesting on April 17, 2028. Each restricted share unit represents a contingent right to receive one ordinary share of the Company. These shares were retained by the Company in payment of the exercise price of the employee stock options exercised by the Reporting Person. The amount retained by the Company was not in excess of the amount of the exercise price. Represents a transaction price of NIS 273.97, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.907 as of the date immediately preceding the date of the transaction. Represents a transaction price of NIS 270.47, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.907 as of the date immediately preceding the date of the transaction. Stock options were granted on September 30, 2021, with 8,875 having vested on each of December 30, 2023, March 30, 2024, June 30, 2024, September 30, 2024, December 30, 2024, March 30, 2025, June 30, 2025, and September 30, 2025. Represents an exercise price of NIS 84.60, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026. Stock options were granted on October 1, 2025, with 12,893 vesting on each of October 1, 2026, and October 1, 2028, and 12,894 vesting on each of October 1, 2027, and October 1, 2029. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only. Performance-based RSUs ("PSUs") were granted on October 1, 2025 and vest in four annual tranches: 2,834 on October 1, 2026, and 2,835 on each of October 1, 2027, 2028, and 2029, subject to continued service as an office holder and achievement of performance metrics for the preceding calendar year. The metrics, Total Income and Revenues, and Adjusted EBITDA (each as reported in the Company's Annual Report on Form 20-F), are measured against the midpoint of the Company's forecast published at the start of the applicable performance year. Achievement of 90% of the target yields 50% vesting for that metric's portion of the tranche, with linear interpolation for achievement between 90% and 100%. Metrics are weighted equally and evaluated independently; overperformance in one cannot offset the other. Each PSU represents a contingent right to receive one ordinary share of the Company upon vesting.